MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ERNA has $10,543K in assets. $3,684K in debts.

Balance Sheets Overview

Current Ratio
289.15%
Quick Ratio
289.15%
Debt to Asset Ratio
34.94%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash
    • Prepaid expenses and other curre...
    • Right-of-use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash
9,177 1,884 3,047 -
Other receivables
-95 153 -
Due from related party
95 750 --
Prepaid expenses and other current assets
724 404 179 -
Total current assets
9,996 3,133 3,379 -
Property and equipment, gross
-291 --
Less accumulated depreciation and amortization
-197 --
Property and equipment, net
88 94 92 -
Right-of-use assets - operating leases, net
349 453 541 -
Goodwill
-2,044 2,044 -
Other assets
110 110 116 -
Total assets
10,543 5,834 6,172 7,584
Accounts payable
1,300 1,125 958 1,319
Accrued expenses
1,481 898 859 938
Income taxes payable
4 3 17 11
Operating lease liabilities, current
163 213 206 217
Due to related party
250 750 --
Contingent consideration liability
41 41 41 41
Other current liabilities
218 83 63 125
Total current liabilities
3,457 3,113 2,144 2,651
Operating lease liabilities, non-current
226 277 346 376
Warrant liabilities
---0
Contingent consideration liability, non-current
---0
Other liabilities
1 43 112 113
Total liabilities
3,684 3,433 2,602 3,140
Preferred stock, 0.005 par value, 1,000 shares authorized, 156 designated and outstanding of series a convertible preferred stock at march 31, 2026 and december 31, 2025, 156 liquidation preference
1 1 1 1
Common stock, 0.005 par value, 150,000 shares authorized at march 31, 2026 and december 31, 2025, 1,166 and 314 issued and outstanding at march 31, 2026 and december 31, 2025, respectively
6 39 39 37
Additional paid-in capital
257,994 247,997 247,656 247,291
Accumulated deficit
-251,142 -245,636 -244,126 -242,885
Total stockholders equity
6,859 2,401 3,570 4,444
Total liabilities and stockholders equity
10,543 5,834 6,172 7,584
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$9,177K Prepaid expenses andother current assets$724K Due from relatedparty$95K Total current assets$9,996K Right-of-use assets -operating leases, net$349K Other assets$110K Property and equipment,net$88K Total assets$10,543K Total liabilities andstockholders equity$10,543K Total stockholdersequity$6,859K Total liabilities$3,684K Accumulated deficit-$251,142K Additional paid-in capital$257,994K Total currentliabilities$3,457K Operating leaseliabilities, non-current$226K Other liabilities$1K Common stock, 0.005 parvalue, 150,000 shares...$6K Preferred stock, 0.005 parvalue, 1,000 shares...$1K Accrued expenses$1,481K Accounts payable$1,300K Due to related party$250K Other currentliabilities$218K Operating leaseliabilities, current$163K Contingent considerationliability$41K Income taxes payable$4K

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Inc. (ERNA)